XML 28 R6.htm IDEA: XBRL DOCUMENT v3.3.0.814
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Operating activities    
Net loss $ (94,747) $ (52,315)
Adjustments to reconcile net loss to net cash used in operating activities:    
Share-based compensation expense 12,997 17,022
Depreciation and amortization 757 875
Loss on debt extinguishment 1,211  
Provision for inventory reserve 754  
Noncash interest expense 351 547
Change in value of warrant liability (135) 886
Other (128) 317
Changes in operating assets and liabilities:    
Accounts receivable 1,253 (1,033)
Other receivable   (17,674)
Inventory 510 115
Prepaid expenses and other current assets (652) 851
Other assets 771 (753)
Accounts payable 7,119 1,384
Accrued expenses (2,504) 6,106
Deferred revenue (681) 278
Other liabilities 3 (5)
Total adjustments 21,626 8,916
Net cash used in operating activities (73,121) (43,399)
Investing activities    
Purchases of property and equipment (31) (258)
Net cash used in investing activities (31) (258)
Financing activities    
Proceeds from common stock offering 15,700  
Proceeds from Hercules debt, net of issuance costs 5,870 (73)
Repayment of Hercules debt (4,659)  
Proceeds from Baxalta milestone advance 32,000  
Payment of tax withholding obligations related to stock compensation (580) (167)
Other 83 61
Net cash provided by (used in) financing activities 48,187 (179)
Effect of exchange rate changes on cash and cash equivalents 387 2,107
Net decrease in cash and cash equivalents (24,578) (41,729)
Cash and cash equivalents at beginning of period 70,933 71,639
Cash and cash equivalents at end of period 46,355 29,910
Supplemental disclosure of cash flow information    
Cash paid during the period for interest 1,507 1,383
Supplemental disclosure of noncash financing and investing activities    
Issuance of common stock upon exercise of common stock purchase warrants   $ 1,877
Repayment and issuance of Hercules debt 13,815  
Series 21 Preferred Stock    
Financing activities    
Cash paid for Series 21 preferred stock issuance costs $ (227)